These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 25844060
1. The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients. Klinzing S, Brandi G, Stehberger PA, Raptis DA, Béchir M. BMC Anesthesiol; 2014; 14():103. PubMed ID: 25844060 [Abstract] [Full Text] [Related]
2. Prognostic evaluation of patients undergoing living-donor liver transplant by APACHE II and MELD scores. Zhang ZY, Chen R, Zhou ZQ, Peng CH, Zhou GW. Exp Clin Transplant; 2015 Feb; 13(1):41-5. PubMed ID: 24779711 [Abstract] [Full Text] [Related]
3. Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients. Oberkofler CE, Dutkowski P, Stocker R, Schuepbach RA, Stover JF, Clavien PA, Béchir M. Crit Care; 2010 Feb; 14(3):R117. PubMed ID: 20550662 [Abstract] [Full Text] [Related]
4. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis. Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Chen DZ. Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514 [Abstract] [Full Text] [Related]
5. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients. Inal MT, Memiş D, Kargi M, Sut N. J Crit Care; 2009 Sep; 24(3):329-34. PubMed ID: 19327336 [Abstract] [Full Text] [Related]
10. Liver Transplantation in Recipients With High Model for End-stage Liver Disease Score. González Martínez S, Molina Raya A, Becerra Massare A, Muffak Granero K, Villegas Herrera T, Villar Del Moral JM, Fundora Suárez Y. Transplant Proc; 2018 Mar; 50(2):595-597. PubMed ID: 29579862 [Abstract] [Full Text] [Related]
12. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis. Cheng XP, Zhao J, Chen Y, Meng FK, Xu B, Yu HW, Meng QH, Liu YM, Zhang SB, Meng S, Zhang JY, Zhang JY, Duan ZP, Zheng SJ. Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802 [Abstract] [Full Text] [Related]
13. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year. Rostved AA, Lundgren JD, Hillingsø J, Peters L, Mocroft A, Rasmussen A. Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374 [Abstract] [Full Text] [Related]
14. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Agopian VG, Petrowsky H, Kaldas FM, Zarrinpar A, Farmer DG, Yersiz H, Holt C, Harlander-Locke M, Hong JC, Rana AR, Venick R, McDiarmid SV, Goldstein LI, Durazo F, Saab S, Han S, Xia V, Hiatt JR, Busuttil RW. Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434 [Abstract] [Full Text] [Related]
15. Risk Factors of Prolonged ICU Stay in Liver Transplant Recipients in a Single-Center Experience. Niewińsk G, Raszeja-Wyszomirska J, Główczyńska R, Figiel W, Zając K, Kornasiewicz O, Zieniewicz K, Grąt M. Transplant Proc; 2018 Sep; 50(7):2014-2017. PubMed ID: 30177100 [Abstract] [Full Text] [Related]
17. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Levesque E, Saliba F, Benhamida S, Ichaï P, Azoulay D, Adam R, Castaing D, Samuel D. Liver Transpl; 2009 Oct; 15(10):1358-64. PubMed ID: 19790157 [Abstract] [Full Text] [Related]
18. Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation. Olmedilla L, Lisbona CJ, Pérez-Peña JM, López-Baena JA, Garutti I, Salcedo M, Sanz J, Tisner M, Asencio JM, Fernández-Quero L, Bañares R. Transplantation; 2016 Mar; 100(3):613-20. PubMed ID: 26569066 [Abstract] [Full Text] [Related]